Make your voice heard! The Centers for Medicare & Medicaid Services (CMS) wants to hear from you about your experience with the drugs selected for the current cycle of negotiation and renegotiation.
How to Get Involved
Register to participate in a virtual, patient-focused roundtable event or speak at the virtual, livestreamed town hall meeting focused on clinical considerations regarding the drugs selected for the current cycle of negotiation and renegotiation. Learn more about the Negotiation Program public engagement events taking place April 2026 and submit your interest form today by accessing the CMS Public Engagement Events website. Registration for the events is open through March 6, 2026.
Provide information about these drugs, including your personal experience taking these drugs or their therapeutic alternatives, by completing the Drug Price Negotiation Information Collection Request (ICR). The ICR is available and responses are due by March 1, 2026.
Reach out to IRARebateandNegotiation@cms.hhs.gov using the subject line “Public Engagement” with any questions.
The Negotiation Program provides Medicare the ability to directly negotiate the prices of certain high-cost drugs.
CMS is currently preparing for the upcoming cycle of negotiation and renegotiation and is committed to engaging with a range of stakeholders as part of the Negotiation Program. Public engagement events are part of CMS’ effort to hear directly from patients, caregivers, clinicians, and others to gather input relevant to the selected drugs.
CMS is also asking the public to provide information about these drugs, including personal experience taking these drugs and therapeutic alternatives, by completing the Drug Price Negotiation Information Collection Request (ICR).
CMS invites you to leverage your organization’s communication channels to share information about these upcoming input opportunities and rally the communities you represent to contribute their perspectives. Additional information will be provided soon.
Key Dates
Drugs selected for the upcoming cycle of negotiation and renegotiation will be announced by February 1, 2026, and registration for public engagement events will follow the announcement of selected drugs
The Drug Price Negotiation ICR will be available by February 1, 2026, and responses are due by March 1, 2026
Public engagement events will be held in spring of 2026
In the meantime, learn more about past public engagement events and how to become involved here.
More information about the Drug Price Negotiation ICR is available here.
Reach out to IRARebateandNegotiation@cms.hhs.gov using the subject line “Public Engagement” with any questions.
Thank you for your support.
Sincerely,
CMS